Image credit: AP Photo/Kathy Young

In a First, a Cannabis-Derived Pharma Product Is Descheduled in the US

The DEA has taken Epidiolex, a CBD-based formula for rare forms of epilepsy, completely off its list of controlled substances. Why? The 2018 Farm Bill.

CBD
Arizona

Arizona: A Cannabis Legalization Initiative Qualifies for the November Ballot

An adult use ballot initiative failed to get enough votes in 2016, while voters in four other states legalized cannabis.

Texas

Texas: A Thin Line Between Over the Counter and Licensed Medical CBD Products

Under new rules, a limited “low-THC” medical program must coexist with retail products in a somewhat blurry regulatory framework.

CBD

Here’s What Else We Know About the White House Meetings on CBD

Among the new names on the list of entities seeking to discuss the FDA’s forthcoming rules on CBD products: American Bankers Association and Columbia Care.